Cytavis Biopharma GmbH
2 clinical trials · Sponsor
◉ Watch Cytavis Biopharma GmbH
| Record | Firm | Date |
|---|---|---|
| CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer (NCT00932724) | Cytavis Biopharma GmbH | 2009-07-01 |
| CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy (NCT00658437) | Cytavis Biopharma GmbH | 2008-04-01 |
Track Cytavis Biopharma GmbH automatically
Every clearance here is in the API, with alerts when new ones post.